Narrow Results

The Appearance and Development of Commercial Laboratories in China.

Independent Medical Laboratories in China - A Sunrise Industry under the Circumstances of Healthcare Reformation.

Tracing the Rise of KingMed and its Future Route - A Correspondence with Hongbo Li.

Establishment of IML Quality Managerial System in China.

The Collaboration between IML and Community Medical Hospitals: Supplementary Service with Tests, Technologies and Beyond.

The Collaboration between IML and Major Medical Institutions - Supplement Service with Esoteric Testing.

Notice from Ministry of Health on Printing and Distributing "Basic Standards for Medical Laboratory (on Trial)" - Ministry of Health of the People's Republic of China.

Yak genome provides new insights into high altitude adaptation.

Gentris and Shanghai Institutes of Preventative Medicine expand collaboration.

Chinese researchers identify rice gene enhancing quality, productivity.

Quintiles opens new Center of Excellence in Dalian to support innovative drug development.

BGI demonstrated genomic data transfer at nearly 10 gigabits per second between US and China.

Quintiles deepens investment in China - New Quintiles China Headquarters and local lab testing solution announced.

Beike earns AABB Accreditation for cord blood and cord tissue banking.

Epigenomic differences between newborns and centenarians provide insight to the understanding of aging.

Metabolic Syndrome and Diabetes: Current Asian Perspectives.

A Crisis in the Development of Antibiotics.

The Marketing of Unapproved Stem Cell Products: An Industry-wide Challenge.

Draining the Goodwill of Science – The Direct-to-Consumer Genetic Testing Industry in East Asia.

Biodiesel – From Lab to Industry.

The Appearance and Development of Commercial Laboratories in China.

Cord Blood Banking – To Go Public or Stay Private.

Open Source – The Future of Drug Discovery.

VACCINES – Where are we headed?

Leveraging on External Expertise.

Asia-Pacific: Falling behind in the fight against HIV/AIDS

The coronavirus (COVID-19) pandemic is one of the biggest challenges in the field of healthcare. Nanomedicine is a developing area that has the potential to treat various diseases and control infections. Now, its applications are open for the treatment of COVID-19. We have studied relevant papers through Scopus, Google Scholar, Science Direct and ResearchGate on nanomedicine in context of COVID-19. This paper provides detailed information about nanomedicine in the context of healthcare. It further identifies the primary challenges faced in the current situation. This study provides details about the advancements in the area of nanomedicine in healthcare for fighting the COVID-19 pandemic. Finally, we have identified and discussed various significant applications of nanomedicine in solving challenges thrown by the COVID-19 pandemic. Researchers can work on developing applications of nanoparticles with the size of the novel Coronavirus. Nanomedicine is helpful to repair the cells of an infected patient the help of repair proteins. It also plays a vital role in testing medicine and helps many clinical trials get approval from healthcare agencies. In the future, nanomedicine will be helpful for fighting against this pandemic and creating advancements in healthcare.